Combined Inhibition of Galphaq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma. Hitchman TD, Bayshtok G, Ceraudo E, Moore AR, et al. Clin Cancer Res 2020 Nov 23. pii: 1078-0432.CCR-20-2860.

Read + Share

Amedeo Smart

Independent Medical Education

Hitchman TD, Bayshtok G, Ceraudo E, Moore AR, et al. Combined Inhibition of Galphaq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma. Clin Cancer Res 2020 Nov 23. pii: 1078-0432.CCR-20-2860.
PMID: 33229459